Harvard Bioscience (HBIO) Shares Outstanding (2016 - 2025)
Historic Shares Outstanding for Harvard Bioscience (HBIO) over the last 17 years, with Q3 2025 value amounting to $44.6 million.
- Harvard Bioscience's Shares Outstanding rose 220.79% to $44.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.6 million, marking a year-over-year increase of 220.79%. This contributed to the annual value of $44.1 million for FY2024, which is 156.47% up from last year.
- According to the latest figures from Q3 2025, Harvard Bioscience's Shares Outstanding is $44.6 million, which was up 220.79% from $44.5 million recorded in Q2 2025.
- In the past 5 years, Harvard Bioscience's Shares Outstanding ranged from a high of $47.7 million in Q1 2021 and a low of $40.5 million during Q2 2021
- Its 5-year average for Shares Outstanding is $42.9 million, with a median of $42.7 million in 2023.
- In the last 5 years, Harvard Bioscience's Shares Outstanding soared by 341.49% in 2021 and then crashed by 1353.36% in 2022.
- Quarter analysis of 5 years shows Harvard Bioscience's Shares Outstanding stood at $41.1 million in 2021, then rose by 2.28% to $42.1 million in 2022, then increased by 3.12% to $43.4 million in 2023, then grew by 1.56% to $44.1 million in 2024, then grew by 1.15% to $44.6 million in 2025.
- Its Shares Outstanding was $44.6 million in Q3 2025, compared to $44.5 million in Q2 2025 and $44.2 million in Q1 2025.